Endonovo Therapeutics, Inc.

Biotechnology • Healthcare • Woodland Hills, CA, United States • ENDV (PNK)

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

800 489 4774 6320 Canoga Avenue, Woodland Hills, CA 91367, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Endonovo Therapeutics Files Patent Application for Cell Therapy Created Using Cord Blood and Tissue Derived Cells - BioInformant

BioInformant • Mar 23

Endonovo Therapeutics gets patent to produce human biomolecules - Proactive Investors

Proactive Investors • Aug 9

Bioelectronics player Rio Grande quits $21.5M Endonovo deal - Fierce Biotech

Fierce Biotech • Aug 22

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury - Multiple Sclerosis News Today

Multiple Sclerosis News Today • Jun 26

Olympian and Champion Surfer Carlos Muñoz Turns To - GlobeNewswire

GlobeNewswire • Mar 15

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has ENDONOVO THERAPEUTICS, INC. had layoffs?

No layoff events have been recorded for ENDONOVO THERAPEUTICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is ENDONOVO THERAPEUTICS, INC. in?

ENDONOVO THERAPEUTICS, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is ENDONOVO THERAPEUTICS, INC. a publicly traded company?

Yes, ENDONOVO THERAPEUTICS, INC. is publicly traded under the ticker symbol ENDV on the PNK. The company has a market capitalization of approximately $0.00 billion.

Where is ENDONOVO THERAPEUTICS, INC. headquartered?

ENDONOVO THERAPEUTICS, INC. is headquartered in Woodland Hills, CA, United States at 6320 Canoga Avenue, Woodland Hills, CA 91367, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.